Rose Medical Center September 01, 2015

FOR IMMEDIATE RELEASE 

MEDIA CONTACT:                                                                                                             
Abigail Kesner
Director, Marketing, Public Affairs

Work: 303.320.2819; Cell: 917.750.2272

FDA Approves Effective, Non-Surgical Weight-Loss Solution

Denver Dr. Michael Snyder the 1st in the region and among the 1st in the country to perform this procedure

(DENVER) –August 31, 2015 – Patients looking to lose their baby weight, get ready for a class reunion, get back into their “real size” jeans, or actually weigh what they told the DMV now have a simple and effective non-surgical solution available to them thanks to recent U.S. Food and Drug Administration (FDA) approval. The FDA just approved the ORBERA™ Intragastric Balloon to assist adult patients suffering from obesity – with a body mass index (BMI) of 30 to 40 – in losing and maintaining weight.

Dr. Michael Snyder at the Denver Center for Bariatric Surgery at Rose Medical Center in Denver, Colo. participated in the FDA trial leading to approval of the balloon procedure. Snyder and will be one of the first physicians in the country and the first in the region to offer this new weight-loss system.

“Everyone can imagine their lives if they lost 20 or 30 pounds,” says Dr. Snyder.  “Thanks to the ORBERA™ Balloon, we can help make it a little easier to get there. Previously, your only options were to eat better, exercise more, and have surgery. The balloon offers a non-surgical solution that can really change people’s lives.”

Until now only bariatric surgery has been proven to provide durable weight loss for people living with obesity. The ORBERA™ Balloon is a non-surgical, FDA-approved and scientifically proven weight loss system placed for a short time to help patients achieve their weight loss goals, improve their weight-related medical issues, and improve their quality of life. Data on ORBERA™ collected in the U.S. clinical trial has shown that the average person lost more than three times the weight as compared with diet and exercise alone within six months and maintained their weight loss.

The balloon is placed temporarily in the stomach via a brief, non-surgical endoscopic procedure performed in an outpatient setting. Patients go home the same day. The balloon remains in the stomach for six months, after which time it is removed via nearly identical outpatient procedure. Intensive post-balloon medical monitoring and nutritional therapy continues for an additional six months. The one-year program is designed to help the patient develop sustainable, healthy habits that will help keep weight off over time.

Dr. Michael Snyder trained with international doctors to implant the ORBERA™ Balloon and participated in the FDA clinical trial. Dr. Snyder is a board-certified bariatric surgeon with Denver Center for Bariatric Surgery and the bariatric medical director for Rose Medical Center in Denver, Colo. The Denver Center for Bariatric Surgery at Rose is a recognized leader in bariatrics in the region and is an 
MBSAQIP Accredited Center with Adolescent Qualifications – one of the longest standing Centers of Excellence since 2004.


About Rose Medical Center

Well known as a Denver institution and a 9th Avenue landmark for more than 60 years, Rose Medical Center has earned its reputation as Denver's "Baby Hospital" while becoming a leader in comprehensive women's, surgical and endoscopy services, heart and vascular, orthopedics, total joint replacement, bariatrics, and sports, internal and aesthetic medicine. With origins in Jewish teachings, traditions and community, Rose’s founders built this hospital to “serve the need of every creed.” By offering a high level of expertise and service across all disciplines, Rose has truly become a destination hospital, attracting patients from throughout Colorado and around the world. Learn more at www.rosemed.com.